Form 8-K Valeant Pharmaceuticals For: Sep 28
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/11/2026
- Wall St climbs after August inflation report, oil price slide
- Oracle raises full year profit guidance, stock rises after hours
- Oil falls but on track for 8% weekly gain on supply concerns; US diesel hits record high
- 'No panic anywhere' may be the problem, BofA strategists warn
- Buy Shopify stock at this ’AI-enabled entry point,’ analyst says
- White House copper tariff plan stalls amid affordability concerns, sources say
- Micron's Taiwan workers to get rewards worth up to 68 months of pay
- Crude Inventory 0.4M Barrels Last Week - EIA
- Vertiv shares drop on acquisition skepticism, AI pullback
- S&P 500, Dow futures attempt recovery ahead of inflation report
- After-Hours Movers: ORCL, CRWV, ADBE, ACVA, CPRT, ZUMZ, PMTS, RH
- After-Hours Movers: COO, AEO, NAVN, AVAV, TORO
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
Valeant Pharma (VRX) Mentioned Cautiously in Blog
September 28, 2015 11:35 AM EDTValeant Pharma (NYSE: VRX) was mentioned cautiously in a blog post on Seeking Alpha (link).
Valeant Pharma (VRX) Updates on Recent Stock Price Action; Refutes Media Speculation
September 28, 2015 8:06 AM EDTOn September 28, 2015, Valeant Pharma (NYSE: VRX) distributed a letter to its employees relating to recent changes in Valeants stock price.
Dear Colleagues:
A number of you have asked me and other senior members of our management team about the significant drop in our stock price especially over the past 5 trading days. While the entire pharmaceutical and biotech sector has been impacted by market... More
